HOME >> BIOLOGY >> NEWS
Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults

>

22% to 28% of the adults studied experienced the onset of bipolar disorder prior to the age of 13. In the interval between onset of illness and initial treatment, patients are at risk of disability and comorbid conditions such as anxiety and substance abuse. Moreover, some children with bipolar disorder are diagnosed with ADHD or depression and receive treatment for long periods of time with only stimulants or antidepressants, rather than combination medications such as mood stabilizers or atypical antipsychotics, as recommended in most treatment guidelines for bipolar disorder. As stated by Dr. Russell Scheffer from the Medical College of Wisconsin in an editorial that accompanies the study, The information contained in this report and additional mounting evidence suggest that early detection, diagnosis, and treatment are essential for determining effective treatment outcomes and, subsequently, quality of life for those affected with bipolar disorder. Earlier recognition and treatment of bipolar disorder in children and adolescents could positively impact the course of illness.


'"/>

Contact: Alice M. Landwehr
journal.pediatrics@cchmc.org
513-636-7140
Elsevier Health Sciences
1-May-2007


Page: 1 2

Related biology news :

1. Delayed breeding is not necessarily costly to lifetime reproductive success
2. New system of wastewater treatment could reduce the size of treatment plants by half
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Geisinger scientist seeks cure for Lou Gehrigs disease, creating device to find treatment
5. System to analyze beating heart stem cells could lead to heart attack treatments
6. Gene expression pattern could lead to improved treatment of pediatric septic shock
7. Molecular detectors may refine cancer treatment
8. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
9. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
10. Scientists take next step in understanding potential target for ovarian cancer treatment
11. New treatment model for HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , ... fibrotic diseases, today announced that Dr. Stacie Canan has joined the company as ... previously served as Executive Director of Global Health at Bristol Myers Squibb (formerly ...
(Date:8/26/2020)... , ... August 25, 2020 , ... Modality Solutions, ... Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking ... 2019 as well, and for this year’s list, reported three-year revenue growth of 71 ...
(Date:8/21/2020)... ... August 19, 2020 , ... ... and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more than twenty years. ... published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... and CEO has been named one of the 100 most inspiring individuals in ... 100 honorees are selected based on how they have inspired their colleagues and ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... the life sciences industry, today announced the release of its signature product ... Medical Science Liaisons (MSLs) and other field medical professionals. , Beacon ...
Breaking Biology Technology:
Cached News: